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Abstract
Background: There are no risk algorithms for the onset of anxiety syndromes at 12 months in primary care. We aimed to
develop and validate internally a risk algorithm to predict the onset of anxiety syndromes at 12 months.
Methods: A prospective cohort study with evaluations at baseline, 6 and 12 months. We measured 39 known risk factors
and used multilevel logistic regression and inverse probability weighting to build the risk algorithm. Our main outcome was
generalized anxiety, panic and other non-specific anxiety syndromes as measured by the Primary Care Evaluation of Mental
Disorders, Patient Health Questionnaire (PRIME-MD-PHQ). We recruited 3,564 adult primary care attendees without anxiety
syndromes from 174 family physicians and 32 health centers in 6 Spanish provinces.
Results: The cumulative 12-month incidence of anxiety syndromes was 12.2%. The predictA-Spain risk algorithm included
the following predictors of anxiety syndromes: province; sex (female); younger age; taking medicines for anxiety, depression
or stress; worse physical and mental quality of life (SF-12); dissatisfaction with paid and unpaid work; perception of financial
strain; and the interactions sex*age, sex*perception of financial strain, and age*dissatisfaction with paid work. The C-index
was 0.80 (95% confidence interval = 0.78–0.83) and the Hedges’ g = 1.17 (95% confidence interval = 1.04–1.29). The Copas
shrinkage factor was 0.98 and calibration plots showed an accurate goodness of fit.
Conclusions: The predictA-Spain risk algorithm is valid to predict anxiety syndromes at 12 months. Although external
validation is required, the predictA-Spain is available for use as a predictive tool in the prevention of anxiety syndromes in
primary care.
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Introduction
Anxiety disorders occur in 6–12% of the general population [1–
2], reaching 18.5% in primary care attendees [3]. Of patients with
an anxiety disorder, 50% have another comorbid psychiatric
condition such as depression or another anxiety disorder [4]. This
results in a loss of 805 quality-adjusted life-years annually per
100,000 primary care patients, thus surpassing chronic physical
illnesses such as cardiovascular diseases, hypertension, diabetes or
chronic obstructive pulmonary disease [5].
Whilst great progress has been made in the development of
effective psychological and pharmacological therapies for anxiety
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[6], these are either not accessed by most persons [7] or they are
not applied correctly [8]. Accordingly, in addition to improving
the process of the clinical care of patients with anxiety,
recommendations suggest developing preventive programs. The
latter require a clear understanding of the associated risk factors
[9]. A prospective study of these risk factors, followed over time
and modeled on large population-based samples, enables the
development of a risk model for developing an anxiety disorder.
This can inform individualized preventive therapies based on this
perception of overall risk [10]. A risk algorithm (PredictA-Europe)
to predict the onset of generalized anxiety and panic syndromes at
6 and 24 months already exists for European primary care
attendees [11]. However, a prediction period of 6 months may be
too short if we consider that the symptoms must last at least 6
months to fulfill the DSM-IV diagnosis of generalized anxiety
disorder. Furthermore, a period greater than 12 months may
include people who have developed more than one episode of
anxiety. We therefore aimed to develop and internally validate a
risk algorithm to predict the onset of anxiety syndromes at 12
months in primary care attendees.
Method
Design and setting
We undertook a prospective cohort study with evaluations at
baseline, 6 and 12 months. Although this cohort was originally
recruited with the aim of developing a risk model for the onset of
major depression [12], in this analysis we aimed to predict the
onset of anxiety syndromes.
The method has been described in detail elsewhere [12]. The
predictA-Spain study was conducted with the participation of 32
health centers and 174 family physicians (FPs) distributed
throughout Spain: Granada in southern Spain; Saragossa and
La Rioja in northern Spain; Madrid, capital of Spain, situated in
the center; Las Palmas in the Canary Islands; and Majorca in the
Balearic Islands. Each health center covers a population of
15,000–30,000 inhabitants from a geographically defined area.
The physicians in each health center work as a group, with
extensive primary care teams. The Spanish National Health
Service provides free medical cover to 95% of the population.
Patients can visit their FP as often as they wish without having to
pay for it, even when they do so for preventive reasons. Each
patient is assigned to only one FP, who has gatekeeper functions.
The health centers taking part cover urban and rural settings in
each province.
Sampling and exclusion criteria
In the six Spanish provinces, systematic random samples from
physician appointment lists were taken at regular intervals of
between four and six attendees with random starting points for
each day. The FPs introduced the study to the selected patients
and requested their permission before contacting the researcher.
Participants who gave informed consent undertook a research
interview within two weeks. The study population was recruited
between October 2005 and February 2006. Exclusion criteria
were an inability to understand or speak Spanish, severe mental
disorder (e.g. psychosis, bipolar), dementia or severe neurological/
sensory illness, terminal illness, the person was scheduled to be out
of the city for more than three months during the 12 months of
follow-up, and persons (representatives) who attended the surgery
on behalf of the person who had the appointment.
Variables
Outcome measure. The outcome of interest was anxiety
syndromes over the preceding 6 months as defined by the anxiety
section of the Primary Care Evaluation of Mental Disorders,
Patient Health Questionnaire (PRIME-MD-PHQ) [13,14]. The
Spanish version of the PRIME-MD classifies patients who test
Figure 1. Flow chart of patients through the predictA-Spain study and numbers becoming anxious. Footnote to Figure 1: DNA: did not
attend; T0, T6 and T12: baseline, 6 and 12 months interview. Anxiety syndromes measured by the Primary Care Evaluation of Mental Disorders, Patient
Health Questionnaire (PRIME-MD-PHQ). 12,13
doi:10.1371/journal.pone.0106370.g001
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positive for panic, generalized anxiety and other anxiety disorders
[14]. The first two diagnoses match the DSM-IV criteria exactly,
but the third is nonspecific. We used a dichotomous anxiety
variable to indicate when any of the three diagnoses of anxiety
were present in a given patient.
Potential risk factors measure. We selected 39 potential
risk factors for which there was evidence of reliability and validity
in the questionnaires used to evaluate them [12]. Baseline
measurements were made of all the potential risk factors:
N Socio-demographic factors: (1) age, (2) sex, (3) marital status,
(4) occupation, (5) employment status, (6) ethnicity, (7)
nationality, (8) country of birth, (9) educational level, (10)
income, (11) owner-occupier of their accommodation, (12)
living alone or with others.
N Controls, demands and rewards for (13) paid and (14) unpaid
work, using an adapted version of the job content instrument
with 7 items each [12,15].
N (15) Debt and financial strain by means of three questions with
Likert responses [16]: 1) General financial strain: ‘‘How well
would you say you are managing financially these days?’’ (4-
Likert); 2) Basic financial strain: ‘‘How often does it happen
that you do not have enough money to afford the kind of food
or clothing you/your family should have?’’ (5-Likert); and 3)
Coping with debts: ‘‘How much difficulty do you have in
meeting the payments of household and other bills?’’ (6-Likert).
N (16) Physical and (17) mental well-being, assessed by the 12-
item Short Form (SF-12) [17,18] and (18) a question on the
presence of long-standing illness, disability or infirmity.
N (19) Alcohol misuse, assessed by the Alcohol Use Disorders
Identification Test (AUDIT) [19–21].
N (20) A screen for lifetime depression based on the first two
questions of the Composite International Diagnostic Interview
(CIDI) [22].
N (21) Lifetime use of recreational drugs (CIDI) [23].
N Brief questions on the quality of (22) sexual and (23) emotional
relationships with a partner, adapted from a standardized
questionnaire [24].
N (24) DSM-IV diagnosis of major depression in the preceding 6
months using the CIDI [23,25,26].
N (25) A question on taking medication for anxiety, depression or
stress.
N Childhood experiences of (26) physical, (27) emotional or (28)
sexual abuse [27].
N (29) Nature and strength of spiritual beliefs [28].
N (30) Presence of serious physical or psychological disorder, or
substance misuse problems, or any serious disability in persons
who were close friends or relations of participants.
N (31) Difficulty getting on with people and maintaining close
relationships, assessed using questions from a social functioning
scale [29].
N (32) History of serious psychological problems or (33) suicide in
first-degree relatives [30].
N (34) Satisfaction with the neighborhood and (35) perceived
safety inside/outside the home using questions from the Health
Survey for England [31].
N (36) Threatening events in the preceding 6 months using the
List of Threatening Experiences Questionnaire [32,33].
N (37) Experiences of discrimination in the preceding 6 months
on grounds of sex, age, ethnicity, appearance, disability, or
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sexual orientation, using questions from a European study
[34].
N (38) Adequacy of social support from family and friends [35].
N (39) Two questions about smoking habits [36].
Statistical Analysis
Participants with missing anxiety diagnoses at both follow-up
points (at 6 and 12 months) were excluded. We also excluded those
with missing anxiety diagnoses at one follow-up point who had no
anxiety syndromes at the other. However, we included patients
with anxiety syndromes at one follow-up point and missing
diagnoses at the other (at 6 or 12 months), as they met the outcome
criterion of anxiety at some point over the 12 months. We
performed multilevel logistic regression with cumulative anxiety
incidence as the dependent variable and health center as a random
component. To test the hierarchical data structure we used the
likelihood-ratio test of the null model taking cumulative incidence
of anxiety syndromes at 12 months as the dependent variable and
health center as a random factor versus usual logistic regression
[Chi2 = 28.94; p,0.0001]. The Intraclass Correlation Coefficient
for Health Center was 0.082 (95% Confidence Interval: 0.039–
0.166). The likelihood-ratio test of the null model with the variable
doctor as a random factor versus usual logistic regression was also
significant [Chi2 = 12.81; p = 0.0002]. The Intraclass Correlation
Coefficient of the variable doctor was 0.091 (95% Confidence
Interval: 0.044–0.180). We then checked the likelihood-ratio test of
Table 2. Model to predict drop-out.
*Odds Ratio 95% confidence interval p
Province
Granada
Saragossa 1.302 0.840–2.018 0.238
Madrid 1.868 1.191–2.930 0.007
Logron˜o 1.526 0.988–2.357 0.057
Majorca 3.522 2.240–5.537 ,0.001
Las Palmas 1.711 0.996–2.936 0.052
Sex
Female
Male 1.382 1.189–1.607 ,0.001
Age (years) 0.986 0.981–.992 ,0.001
Education
Beyond secondary education
Secondary education 1.240 0.960–1.600 0.099
Primary education 1.328 1.043–1.692 0.022
Incomplete primary education or illiterate 1.594 1.178–2.158 0.002
Enough money to afford food or clothing
Always
Often 1.122 0.912–1.381 0.275
Sometimes 0.982 0.768–1.256 0.885
Seldom 2.141 1.015–4.517 0.046
Never 0.650 0.286–1.479 0.304
Discrimination due to age
No
Yes 1.890 1.169–3.054 0.009
Daily smoker
Non or ex-smoker
Up to 10 cigarettes 1.199 0.941–1.528 0.142
From 11 to 20 cigarettes 1.316 1.034–1.676 0.026
From 21 to 30 cigarettes 0.873 0.573–1.331 0.529
More than 30 cigarettes 1.391 0.773–2.502 0.271
Lifetime depression
No
Yes 1.22 1.048–1.415 0.010
(*) Multi-level logistic regression with health center as a random component. We selected variables included in the final model from the 39 measured in this study using
a threshold for inclusion of p,0.20 in bivariate regression. From the model thus obtained, those variables with p.0.05 were extracted step by step to obtain a more
parsimonious model.
doi:10.1371/journal.pone.0106370.t002
Predicting the Onset of Anxiety Syndromes
PLOS ONE | www.plosone.org 5 September 2014 | Volume 9 | Issue 9 | e106370
T
a
b
le
3
.
M
o
d
e
ls
a
fo
r
p
re
d
ic
ti
n
g
th
e
o
n
se
t
o
f
an
xi
e
ty
at
1
2
m
o
n
th
s
(N
=
2
.1
0
3
).
M
o
d
e
l
w
it
h
o
u
t
in
te
ra
ct
io
n
sb
M
o
d
e
l
w
it
h
in
te
ra
ct
io
n
sc
R
is
k
fa
ct
o
rs
ß
S
.E
.
p
ß
ß
d
S
.E
.
p
C
o
n
st
a
n
t
P
ro
v
in
ce
1
.6
4
7
0
.7
6
9
0
.0
3
2
0
.4
7
5
0
.2
3
8
1
.5
7
8
0
.1
6
1
G
ra
n
ad
a
Sa
ra
g
o
ss
a
0
.9
8
4
0
.2
3
3
,
0
.0
0
1
1
.0
6
4
1
.0
4
2
0
.2
4
1
,
0
.0
0
1
M
ad
ri
d
2
0
.9
7
6
0
.2
4
6
,
0
.0
0
1
2
0
.9
4
1
2
0
.9
2
1
0
.2
7
5
0
.0
0
1
Lo
g
ro
n˜
o
2
0
.3
4
3
0
.2
6
0
0
.1
8
7
2
0
.3
3
3
2
0
.3
2
6
0
.2
8
7
0
.2
4
6
M
aj
o
rc
a
0
.6
9
9
0
.2
3
0
0
.0
0
2
0
.7
4
1
0
.7
2
6
0
.2
4
6
0
.0
0
3
La
s
P
al
m
as
2
0
.3
5
6
0
.3
3
4
0
.2
8
7
2
0
.3
3
3
2
0
.3
2
6
0
.3
4
5
0
.3
3
3
S
e
x Fe
m
al
e
M
al
e
2
0
.4
5
3
0
.1
6
9
0
.0
0
8
2
1
.7
3
5
2
1
.6
9
9
0
.9
6
2
0
.0
7
1
A
g
e
(y
e
ar
s)
2
0
.0
2
3
0
.0
0
6
,
0
.0
0
1
0
.0
1
0
2
0
.0
1
0
0
.0
1
3
0
.4
5
9
F
in
a
n
ci
a
l
st
ra
in
Li
vi
n
g
co
m
fo
rt
ab
ly
D
o
in
g
al
ri
g
h
t
0
.4
8
4
0
.2
4
7
0
.0
5
0
0
.4
9
8
0
.4
8
8
0
.2
9
1
0
.0
8
7
Fi
n
d
in
g
it
d
if
fi
cu
lt
0
.6
2
9
0
.3
1
0
0
.0
4
2
0
.5
4
5
0
.5
3
4
0
.3
7
4
0
.1
4
4
Fi
n
d
in
g
it
ve
ry
d
if
fi
cu
lt
0
.9
4
3
0
.4
0
9
0
.0
2
1
0
.2
9
9
0
.2
9
3
0
.5
2
5
0
.5
6
9
T
a
k
in
g
p
sy
ch
o
tr
o
p
ic
d
ru
g
s
N
o
Y
e
s
0
.6
1
4
0
.2
4
4
0
.0
1
2
0
.6
0
9
0
.5
9
6
0
.2
4
1
0
.0
1
1
P
h
y
si
ca
l
h
e
a
lt
h
(S
F-
1
2
,
ra
n
g
e
=
0
–
1
0
0
)
Ea
ch
p
o
in
t
o
n
su
b
sc
al
e
sc
o
re
2
.0
3
2
0
.0
0
8
,
0
.0
0
1
2
0
.0
3
3
2
0
.0
3
2
0
.0
0
8
,
0
.0
0
1
M
e
n
ta
l
h
e
a
lt
h
(S
F-
1
2
,
ra
n
g
e
=
0
–
1
0
0
)
Ea
ch
p
o
in
t
o
n
su
b
sc
al
e
sc
o
re
2
.0
4
6
0
.0
0
9
,
0
.0
0
1
2
0
.0
4
9
2
0
.0
4
8
0
.0
0
9
,
0
.0
0
1
D
is
sa
ti
sf
a
ct
io
n
w
it
h
p
a
id
w
o
rk
Sa
ti
sf
ie
d
D
is
sa
ti
sf
ie
d
2
0
.0
1
7
0
.2
3
8
0
.9
4
3
2
.2
4
5
2
.1
9
8
1
.0
4
1
0
.0
3
1
V
e
ry
d
is
sa
ti
sf
ie
d
0
.8
7
9
0
.2
5
5
0
.0
0
1
2
.4
6
3
2
.4
1
2
0
.9
2
8
0
.0
0
8
Jo
b
le
ss
0
.4
2
9
0
.2
4
6
0
.0
8
1
2
.1
9
8
2
.1
5
2
0
.5
2
7
,
0
.0
0
1
D
is
sa
ti
sf
a
ct
io
n
w
it
h
u
n
p
a
id
w
o
rk
Sa
ti
sf
ie
d
D
is
sa
ti
sf
ie
d
0
.6
5
4
0
.2
2
0
0
.7
6
7
0
.0
6
4
0
.0
6
3
0
.2
2
9
0
.7
7
9
V
e
ry
d
is
sa
ti
sf
ie
d
1
.0
4
2
0
.3
7
5
0
.0
0
5
1
.1
2
9
1
.1
0
5
0
.3
4
5
0
.0
0
1
N
o
re
sp
o
n
se
0
.1
8
8
0
.2
7
9
0
.5
0
0
0
.1
4
4
0
.1
4
1
0
.2
7
4
0
.5
9
8
S
e
x
*a
g
e
0
.0
2
7
0
.0
2
6
0
.0
1
4
0
.0
5
9
Predicting the Onset of Anxiety Syndromes
PLOS ONE | www.plosone.org 6 September 2014 | Volume 9 | Issue 9 | e106370
the null model with health center and doctor as random factors
versus the null model with only health center [Chi2 = 0.71;
p = 0.2002]. We therefore decided to use multilevel logistic
regression with health center as the random component.
We selected variables using a threshold for inclusion of p,0.20
to ensure that information lost as a result of exclusion of a variable
from the equation was minimal [37]. From the model thus
obtained, those variables with p.0.05 were extracted step by step
to obtain a more parsimonious model. The usefulness of including
first-degree interactions was considered, especially the interaction
age*sex because it has been found previously in depression [38,39]
and anxiety [40], as well as the different combinations of age and
sex with the other variables included in the model. We decided to
include an interaction in the model when the likelihood ratio test
was significant at p,0.05. We used inverse probability weighting
[41,42] to adjust for a possible attrition bias due to participants lost
to follow-up. All reported P values were two-sided.
The ability to distinguish those who would develop anxiety
syndromes from those who would not was assessed using the C-
index [43]. To compare the discriminative validity between two
risk algorithms we performed the test for two correlated C-index.
Prediction models derived with multivariable regression analysis
are known for overestimating regression coefficients. We used a
calculation proposed by Copas [44] to estimate overfitting of our
prediction models. We calculated effect sizes using Hedges’ g [45].
Calibration, which is the agreement between the observed
proportions of major depressive disorder and the predicted risks,
was studied with calibration plots taking deciles of risk. We
conducted all analyses using STATA, release 12 [46].
Ethics Statement
The predictA-Spain study has been conducted according to the
principles expressed in the Declaration of Helsinki. This study
complies with the Code of Ethics of the World Medical
Association and was approved by the ethics committees: Ethics
Committee on Human Research of the University of Granada,
Ethics and Research Committee of Primary Health District of
Malaga, Ethics Committee for Clinical Research of Aragon
(CEICA). Research assistants explained to patients the predictA-
Spain study in detail, their commitments and rights, and answered
all questions that patients wanted to ask. All the participants read
an information sheet and signed consent forms to take part in the
study.
Results
Of the 6,299 primary care attendees approached, 1,251 (19.9%)
were excluded: 506 (8.03%) were outside the age range (18–75
years); 446 (7.1%) were either representatives of patients or did not
attend the appointment; 156 (2.5%) had severe mental disorder,
dementia or severe neurological/sensory illness; 63 (1.0%)
terminal illness; 47 (0.75%) trouble communicating in Spanish;
and 33 (0.52%) were scheduled to be out of the city for longer than
three months during the 12 months of follow-up. Of the remaining
5,048 patients asked to take part in the study 4,166 (82.5%) gave
their consent. These were then interviewed at baseline, but 585
(14.0%) had a positive diagnosis of anxiety syndrome (by PRIME-
MD-PHQ) and 17 (0.41%) had a missing diagnosis, so they were
also excluded. Thus, our at-risk population comprised 3,564
patients (Figure 1).
Patients’ socio-demographic characteristics are shown in
Table 1.
Of the 3,564 patients, 2,420 (68%) were interviewed at 6
months and 2,294 (64.4%) at 12 months. The variables associated
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with drop-outs were province (Madrid and Majorca), sex (male),
lower age, lower educational level, seldom having enough money
to afford food or clothing (basic financial strain), discrimination
due to age, daily smoker, and lifetime depression (see Table 2).
There were only nine missing values for predictor variables in the
final models to predict the onset of anxiety syndromes. The
cumulative 12-month incidence of anxiety syndromes was 12.2%
(panic disorder 4.5%, generalized anxiety disorder 4.1%, other
anxiety disorders 5%).
The final model to predict anxiety syndromes included 9
variables and 3 interactions (Table 3): province; sex (female); lower
age; taking medicines for anxiety, depression or stress; worse
physical and mental life quality (SF-12); dissatisfaction with paid
and unpaid work; perceived general financial strain; and the
interactions sex*age, sex*perceived financial strain, and age*dissa-
tisfaction with paid work. From the 15 interactions tested we
selected the three that had a p,0.05. Firstly, we compared the
nine-variable model plus the interaction sex*age and the nine-
variable model plus the interactions sex*age and sex*financial
strain [chi2= 13.90; p= 0.003]. Secondly, we compared the nine-
variable model plus the interaction sex*age with the nine-variable
model plus the interactions sex*age and age*paid work
[chi2= 11.55; p= 0.009]. Thirdly, we compared the nine-variable
model plus the interactions sex*age and sex*financial strain with
the nine-variable model plus the interactions sex*age, sex*financial
problems, and age*paid work [chi2= 11.76; p= 0.008]. The
likelihood ratios for the interactions analyzed are described in
Table 4 and charts of the three interactions are shown in
Figures 2–3–4.
Concerning the interaction sex*age, whereas the tendency for
the incidence of anxiety in women could be drawn with a more or
less descending line with effect from the age of 25 years, the
tendency for the men rose from the age of 25 years up to 54 years,
with the peak between 45–54 years (Figure 2).
The interaction sex*financial strain showed that in men with
many financial problems the risk for the incidence of anxiety was
increased four-fold (Figure 3).
The interaction age*dissatisfaction at work had an antagonistic
effect, with dissatisfaction at work in the younger patients
increasing the incidence of anxiety (Figure 4).
The shrinkage factor was 0.9793 (shrinkage = 1 indicates that
there is no overestimation). The C-index and effect size (Hedges’ g)
were 0.80 [95% confidence interval (CI) = 0.78–0.83] and 1.17
(95%CI = 1.04–1.29), respectively, and the C-index data are
represented in Figure 5. There was a slight improvement in the
C-index in the model with interactions (0.8024; 95%CI = 0.7763–
0.8284) versus the model without interactions (0.7917;
95%CI = 0.7653–0.8181); Chi2 = 5.11(DF = 1) and p = 0.0238
(Figure 5).
Table 4. Comparison of the base model with the models
including each of the interactions tested.
Interactions
Likelihood-ratios between model without
interactions and model with each interaction
chi2 P
Sex*province#
Sex*age 7.12 0.008
Sex*financial strain 12.98 0.005
Sex*taking
psychotropic drugs
2.60 0.107
Sex*physical health 0.00 0.945
Sex*mental health 1.31 0.253
Sex*paid work 2.70 0.441
Sex*unpaid work 1.42 0.702
Age*province 4.24 0.515
Age*financial strain 3.14 0.371
Age*taking
psychotropic
0.02 0.889
Age*physical health 0.23 0.630
Age*mental health 2.12 0.145
Age*paid work 11.01 0.012
Age*unpaid work 1.36 0.716
#The model sex*province did not converge.
doi:10.1371/journal.pone.0106370.t004
Figure 2. Incidence of anxiety by age and sex.
doi:10.1371/journal.pone.0106370.g002
Figure 3. Incidence of anxiety by sex and level of financial
strain.
doi:10.1371/journal.pone.0106370.g003
Figure 4. Incidence of anxiety by age and dissatisfaction at
work.
doi:10.1371/journal.pone.0106370.g004
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We incorporated depression (measured by the CIDI at baseline)
as a risk factor candidate to be included in the model to predict the
onset of anxiety syndromes but, although it was statistically
significant in bivariate analysis (OR = 2.83; 95% CI = 1.70–4.71;
p,0.0001), it did not remain in the final model after adjustment. If
we removed from the final model the variables ‘‘worse mental life
quality (SF-12-mental) and taking medication for anxiety, depres-
sion or stress’’ and then included major depression (CIDI), the
latter reached statistical significance (OR = 1.88; 95%CI = 1.18–
2.99; p = 0.008); but if we just removed only one of them (SF12-
mental or taking psychotropic agents) then major depression was
not significant. Our final model was clearly more discriminant (C-
index = 0.80; 95%CI = 0.78–0.83) than the model excluding SF12-
mental and taking psychotropic agents and including major
depression (C-index = 0.77; 95%CI = 0.74–0.79); with the test for
its difference being statistically significant [chi2(1) = 14.54;
P = 0.0001].
The calibration showed an accurate goodness of fit (Figure 6).
The predicted probability cut-point of 10% was associated with
the greatest Youden’s J statistic (J = Sensitivity + Specificity -1),
which had good sensitivity (80.2%) but poor specificity (66.5%).
The predicted probability of 11% reached a specificity of 70% and
a sensitivity of 75%; while the predicted probability of 13% had
more specificity (75%) than sensitivity (approximately 69%), see
Table 5.
Differences (variations in coefficients .10%) were found
between the final model and the same model weighted for the
inverse probability of remaining in the follow-up to 12 months
(Table 6). Examples of the kinds of participants scoring at
increasing levels of predicted probability of anxiety syndromes
are shown in Table 7.
Discussion
The predictA-Spain risk algorithm is valid. To our knowledge, it
is the first algorithm that has been developed and internally
validated to predict the onset of anxiety syndromes at 12 months
in primary care attendees. From the shrinkage factor obtained, it
can be deduced that coefficients were minimally over-estimated in
the internal validation process. However, external validations are
required to apply this risk algorithm in different populations. We
used multi-level regression because of the hierarchical structure of
the data. This approach improves the accuracy of estimates of
coefficients and standard errors [47]. Our large sample size and
the number of events (people developing anxiety syndromes) per
variable included in the model reduced the risk of selecting
unimportant variables and failing to include important variables
[48]. However, the sample size was not large enough to address
external validation in this study, derivating the algorithm in some
provinces and validating in the others. Though our sample
possibly under-represented patients who attend infrequently [49],
frequent attendees are more likely to suffer from anxiety disorders
[50] and therefore are most in need of prevention.
Important differences were seen between the predictA-Spain
models with and without inverse probability weighting, indicating
that loss to follow-up might lead to attrition bias and that this
strategy could provide unbiased estimates of coefficients, even in
the presence of attrition bias [41].
The questionnaire used to evaluate our outcome, PRIME-MD,
has good reliability and validity indices [14], but we cannot rule
out classification bias. Moreover, we only considered generalized
anxiety and panic disorders as defined by the PRIME-MD. Our
data do not concern other anxiety disorders such as post-traumatic
stress, obsessive compulsive or phobic anxiety disorders.
In terms of C-index and effect size (Hedges’ g), the predictA-
Spain risk score compares favorably with the predictA-Europe,
Figure 6. Calibration plots (mean predicted probability versus
observed probability of anxiety within deciles of predicted
risk) of the predictA-Spain risk algorithm.
doi:10.1371/journal.pone.0106370.g006
Figure 5. Area under the ROC curve for the models with/
without interactions. Footnote toFigure 5: predictA: model without
interactions predictA3: model with 3 interactions.
doi:10.1371/journal.pone.0106370.g005
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although the differences between the two risk scores might be
explained in part by the greater homogeneity of the sample in
Spain. The predictA-Spain is also similar to other risk algorithms
for the onset of major depression [39,51] as well as for risk indices
for cardiovascular events [52].
The predictA-Spain risk algorithm shared some risk factors with
the predictA-Europe [11] (sex, age, physical and mental quality of
life, and dissatisfaction with paid and unpaid work) but differed in
others: (1) taking medicines for anxiety, depression or stress, (2)
perceived financial problems, and (3) the interactions. Moreover,
the variable dissatisfaction with paid and unpaid work was
measured differently (a dichotomous combined variable in the
predictA-Europe and two separate scales in the predictA-Spain).
The first difference (1) might, in theory, be because that variable
was not included as a candidate in the stepwise selection process in
predictA-Europe.
We are quite sure that our population at risk had no anxiety
syndromes at baseline, at least during the preceding 6 months as
defined by the anxiety section of the PRIME-MD. However, we
cannot rule out that some patients had suffered anxiety syndromes
prior to that date. In addition, our population at risk could have
had depression or dysthymia at baseline or before. For any of these
reasons, patients might be taking (appropriately or inappropriate-
ly) antidepressants and/or anxiolytics at baseline. There may also
be patients (without diagnostic criteria for anxiety or depression
disorders) who had insomnia and for whom a doctor could have
prescribed pills to sleep. In the case of taking anxiolytics over a
long time, along with insomnia, a percentage of the patients could
also have an addiction disorder. Moreover, the question is phrased
in such a way that it might include those taking anxiolytics-
antidepressants or other medicines (vitamins, placebos, etc.), often
inadequately, for minor emotional problems.
Including this variable in the final model does not mean that
taking psychotropic drugs causes anxiety syndromes. If our
objective is to obtain a risk algorithm, all variables potentially
associated with the outcome, not necessarily causally, can be
considered in order to predict as accurately as possible [53]. We
believe that when patients respond that they are taking medication
for anxiety, depression or stress, it should be understood as an
intermediate variable related to one or more mental health
disorder, such as depression, dysthymia, insomnia, addictions,
personality disorders, adjustment disorders or other minor
emotional problems. We have checked this with our data and
this may be true at least in the case of major depression (see the
results section); additionally, suffering other mental disorders is a
well known risk factor for anxiety disorders [54].
One hypothesis to explain the inclusion of this variable in the
predictA-Spain risk algorithm might be that Spanish patients have
a tendency to ask their FPs for more psychotropic drugs for
emotional problems encountered in everyday life and Spanish FPs
tend to give them more medication. There is some support for this
hypothesis because Spain is among those European countries
having a higher use of psychotropic drugs [55].
The question ‘‘taking medication for anxiety, depression or
stress’’ is a little ambiguous, but it is a good and independent
predictor of the onset of anxiety syndromes and it is also very easy
to obtain an answer.
The second difference (2) may be related with the fact that the
economic indicators for Spain are below those of the European
mean [56]. Finally, (3) the fact that the interactions were not
included in the predictA-Europe might be explained because only
the interactions between time and variables were explored in the
model [11].
The selection of risk factors was performed with the aim of
building a predictive model for major depression. However, it is
known that anxiety and depression share most of their risk factors
[11,39,51,57]. The predictA-Spain shared seven risk factors with
the predictD-Spain [39] risk algorithm to predict the onset of
major depression in primary care, although their coefficients were
different. However, five risk factors were only included in the
predictD-Spain, whilst a further four were included in the
predictA-Spain. We highlight the inclusion of dissatisfaction with
paid work and the perception of financial strain, which were good
predictors of anxiety but not depression [39]. Furthermore, the
perception of many financial difficulties by men (interaction
financial strain*sex) quadrupled the incidence of anxiety at 12
months, reaching 80% (see Figure 3); which might trigger a
priority prevention for these cases. This may possibly be explained
by the predominant role of the male in Spanish culture to
maintain the family financially. Thus, given a situation of
maximum hardship the male could either be affected more or
have less capacity than the female to cope adequately. Concerning
the antagonistic interaction sex*age (see Figure 2), a similar result
was found in a study of the prevalence of anxiety in Europe [58].
Table 5. Predicted probability cut-points to predict anxiety syndromes at 12 months and their associated validity.
Predicted probability cut-points Sensitivity (%) Specificity (%) LR+ LR-
$0.0817 84.8 59.9 2.12 0.25
$0.0928 82.5 64.1 2.30 0.27
$0.0998* 80.2 66.5 2.39 0.30
$0.1053 77.4 67.8 2.41 0.33
$0.1108 74.7 69.8 2.48 0.36
$0.1147 72.4 71.0 2.50 0.40
$0.1204 70.0 72.9 2.60 0.41
$0.1291 68.5 75.1 2.75 0.42
$0.1442 65.4 80.0 2.96 0.44
$0.1699 60.3 82.7 3.48 0.48
$0.1860 55.3 84.7 3.62 0.53
LR+ Likelihood ratio of the positive test; LR- Likelihood ratio of the negative test.
*Cutpoint where Youden’s J statistic (J = Sensitivity + Specificity -1) was greater.
doi:10.1371/journal.pone.0106370.t005
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The interaction age*dissatisfaction at work also had an antago-
nistic effect (Figure 4), a possible reason for which is that younger
persons have less work experience and may therefore have less
efficient coping strategies for work problems. The fact that anxiety
and depression share many risk factors could be explained in part
by their frequent co-occurrence, although it is also possible that
Table 6. Weighted and unweighted models* by the inverse probability of remaining in the follow-up to 12 months.
Model weighted Model unweighted
Risk factors ß S.E. p ß S.E. P
Constant Province 0.475 1.578 0.161 0.265 0.893 0.767
Granada
Saragossa 1.064 0.241 ,0.001 0.970 0.242 ,0.001
Madrid 20.941 0.275 0.001 21.010 0.309 0.001
Logron˜o 20.333 0.287 0.246 20.405 0.287 0.157
Majorca 0.741 0.246 0.003 0.672 0.263 0.011
Las Palmas 20.333 0.345 0.333 20.345 0.359 0.336
Sex
Female
Male 21.735 0.962 0.071 21.560 0.886 0.078
Age (years) 0.010 0.013 0.459 0.014 0.016 0.373
Financial problems
Living comfortably
Doing alright 0.498 0.291 0.087 0.454 0.340 0.182
Finding it difficult 0.545 0.374 0.144 0.507 0.376 0.178
Finding it very difficult 0.299 0.525 0.569 0.226 0.652 0.729
Taking psychotropic drugs
No
Yes 0.609 0.241 0.011 0.544 0.176 0.002
Physical health (SF-12)
Each point on subscale score 20.033 0.008 ,0.001 20.030 0.007 ,0.001
Mental health (SF-12)
Each point on subscale score 20.049 0.009 ,0.001 20.048 0.007 ,0.001
Dissatisfaction with paid work
Satisfied
Dissatisfied 2.245 1.041 0.031 2.334 0.953 0.014
Very dissatisfied 2.463 0.928 0.008 2.368 1.094 0.030
Jobless 2.198 0.527 ,0.001 2.072 0.783 0.008
Dissatisfaction with unpaid work
Satisfied
Dissatisfied 0.064 0.229 0.779 0.086 0.188 0.646
Very dissatisfied 1.129 0.345 0.001 1.054 0.275 ,0.001
Not response 0.144 0.274 0.598 0.186 0.284 0.511
Sex*age 0.027 0.014 0.059 0.025 0.012 0.039
Sex*financial problems
Living comfortably
Doing alright 20.157 0.784 0.841 20.276 0.724 0.703
Finding it difficult 0.133 0.98 0.892 0.043 0.793 0.956
Finding it very difficult 4.049 2.231 0.070 3.754 1.607 0.020
Age*paid work
Satisfied
Dissatisfied 20.056 0.026 0.035 20.059 0.023 0.009
Very dissatisfied 20.037 0.023 0.102 20.035 0.025 0.171
Unemployed 20.043 0.013 0.001 20.042 0.017 0.014
S.E.: Standard error. (*) Multi-level logistic regression with health center as a random component.
doi:10.1371/journal.pone.0106370.t006
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both are expressions of a latent pathological process [59]. Their
different phenotypes may be associated with the interaction
between different risk factors in each case, including those not
measured in this study (e.g. genes, personality, coping).
The predicted probability of the onset of anxiety syndromes at
12 months in an individual could be calculated from the equation
in Table 3, adding the constant and the corresponding shrunk
coefficients for each patient and then inverting the ‘‘logit’’ of the
sum obtained. As these calculations are relatively complex, the
most reasonable option is a spreadsheet or a web-based calculator.
Our web-based calculator is available for the onset of major
depression at 12 months [39], and on the same website (http://
www.rediapp.org/predict/Index.php), a calculator will be avail-
able in the coming months for the onset of anxiety syndromes at
12 months.
Our results do not address how the predictA-Spain algorithm
might be implemented in primary care, though this aspect can be
studied in future research. Recognition by FPs of those patients
with a greater overall risk (quantitative risk information) as well as
their risk factors (qualitative risk information) may lead, as in
cardiovascular disease, to the development of interventions
tailored for intensity (level) and specificity (profile) of risk. The
FPs could inform patients about their risk and provide tailored
counseling and support, thus increasing the patients’ empower-
ment and self-efficacy perception to prevent anxiety syndromes
[10].
The choice of a predicted probability cut-point for making
clinical decisions depends mostly on three factors: 1) the validity of
each cut-point; 2) the available evidence on the effectiveness of
interventions to prevent anxiety and whether this effectiveness is
greater for a given predicted probability cut-point; and 3) the
available evidence on the consequences of false positives and
negatives regarding patients’ health and quality of life and costs for
patients, health services and society. For example, if an effective
intervention to prevent anxiety is implemented by FPs, since FPs
are usually very busy a more specific cut-point to intervene might
be preferable (e.g., a predicted probability of 13–14% or greater);
although this decision should be reconsidered in light of the
available data on the consequences to health and cost of false
negative predictions. Nonetheless, if we provide a low cost
intervention to prevent depression (e.g., an internet-based guided
self-help) and the consequences linked to the false positives are
acceptable, a more sensitive cut-point might be interesting (e.g., a
predicted probability of 10%). Interventions to prevent anxiety
disorders have been developed mainly in children and adolescents
[60,61], and less frequently in the elderly [62,63]. However,
further evaluations are needed of the effectiveness of interventions
to prevent anxiety disorders in general adult populations.
Conclusion
The predictA-Spain risk algorithm is valid to predict anxiety
syndromes at 12 months. Although external validation is required,
the predictA-Spain is available for use as a predictive tool in the
prevention of anxiety syndromes in primary care.
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